Fagan Associates, Inc. Bristol Myers Squibb CO Transaction History

Fagan Associates, Inc.

$571 Million
Q3 2024

A detailed history of Fagan Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fagan Associates, Inc. holds 5,727 shares of BMY stock, worth $337,148. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,727

Holding current value

$337,148

% of portfolio

0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $227,132 - $296,372	5,727 New	5,727 $296,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $3,005 - $3,586	-62 Reduced 1.29%	4,727 $242,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $4,778 - $5,305	-75 Reduced 1.54%	4,789 $306,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $2.93 Million - $3.41 Million	-54,555 Reduced 91.81%	4,864 $303,000
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $273,720 - $320,628	4,626 Added 8.44%	59,419 $3.52 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $28,478 - $31,013	460 Added 0.85%	54,793 $3.66 Million
Q1 2021 May 06, 2021	BUY	$59.34 - $66.74 $602,894 - $678,078	10,160 Added 23.0%	54,333 $3.43 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $22,287 - $25,255	386 Added 0.88%	44,173 $2.74 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $34,458 - $38,184	600 Added 1.39%	43,787 $2.64 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $752,733 - $880,019	13,731 Added 46.62%	43,187 $2.54 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $433,422 - $629,863	9,341 Added 46.44%	29,456 $1.64 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $633,086 - $825,804	12,865 Added 177.45%	20,115 $1.29 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $310,082 - $367,647	7,250 New	7,250 $368,000
Q2 2019 Jul 12, 2019	SELL	$44.62 - $49.34 $192,312 - $212,655	-4,310 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $3,609 - $4,304	-80 Reduced 1.82%	4,310 $206,000
Q4 2018 Feb 05, 2019	BUY	$48.76 - $63.23 $22,185 - $28,769	455 Added 11.56%	4,390 $228,000
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $24,835 - $28,012	-450 Reduced 10.26%	3,935 $244,000
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $135,673 - $169,101	-2,685 Reduced 37.98%	4,385 $243,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $5,992 - $6,898	-100 Reduced 1.39%	7,070 $447,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $43,456 - $47,378	-725 Reduced 9.18%	7,170 $439,000
Q2 2017 Aug 07, 2017	BUY	N/A	7,895	7,895 $440,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.

Account

Fagan Associates, Inc. Bristol Myers Squibb CO Transaction History